Iwicki Mark T Insider Trades

Insider Trading History

Track insider trading activity for Iwicki Mark T. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $181k 9,810 shares
Last Trade
Jun 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$124k 9,810 shares
$12.64
$18.46
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Chief Executive Officer
Holding Value $10.3M 4,982,706 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10M 4,982,706 shares
$2.01
$2.06
Merus N.V
Merus N.V MRUS
Director
Holding Value $0 0 shares
Last Trade
Dec 12, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$8.43M 86,939 shares
$96.91
$90.00
Merus N.V
Merus N.V MRUS
Director
Holding Value $0 0 shares
Last Trade
Dec 12, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$7.14M 73,576 shares
$97.00
$90.00
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$13.6M 249,705 shares
$54.65
$54.65
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $988k 53,521 shares
Last Trade
Oct 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 53,521 shares
$2.80
$18.46
Kala Bio
Kala Bio KALA
Director
Holding Value $99.7k 103,540 shares
Last Trade
Oct 23, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$125k 154,894 shares
$0.81
$0.96
Third Harmonic Bio
Third Harmonic Bio THRD
Director
Holding Value $0 0 shares
Last Trade
Aug 11, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$688k 128,631 shares
$5.35
$5.38
Kala Bio
Kala Bio KALA
Director
Holding Value $249k 258,433 shares
Last Trade
Jun 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$53k 13,227 shares
$4.01
$0.96
Kala Bio
Kala Bio KALA
Director
Holding Value $262k 271,660 shares
Last Trade
Jun 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.4k 5,450 shares
$4.30
$0.96
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $514k 9,398 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$485k 9,398 shares
$51.61
$54.65
Kala Bio
Kala Bio KALA
Director
Holding Value $259k 269,210 shares
Last Trade
Jun 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$40.6k 10,866 shares
$3.74
$0.96
Kala Bio
Kala Bio KALA
Director
Holding Value $259k 269,210 shares
Last Trade
Jun 03, 2025 Purchase (Open Market)Shares sold on the open market or in a private sale.
$40.6k 10,866 shares
$3.74
$0.96
Merus N.V
Merus N.V MRUS
Director
Holding Value $1.19M 13,193 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$549k 13,193 shares
$41.60
$90.00
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $0 0 shares
Last Trade
Feb 24, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$84.2k 33,149 shares
$2.54
$18.46
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $687k 37,222 shares
Last Trade
Feb 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$179k 70,371 shares
$2.54
$18.46
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Chief Executive Officer
Holding Value $1.24M 602,346 shares
Last Trade
Feb 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.79M 602,346 shares
$2.97
$2.06
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Chief Executive Officer
Holding Value $1.24M 602,346 shares
Last Trade
Feb 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.79M 602,346 shares
$2.97
$2.06
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Chief Executive Officer
Holding Value $3.7M 1,794,291 shares
Last Trade
Feb 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.22M 1,794,291 shares
$2.35
$2.06
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Chief Executive Officer
Holding Value $9.01M 4,373,857 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.3M 4,373,857 shares
$2.35
$2.06

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up